Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899140-08-001308
Filing Date
2008-06-10
Accepted
2008-06-10 16:38:53
Documents
2
Period of Report
2001-07-15

Document Format Files

Seq Description Document Type Size
1 orassoc_accp3-060208ex.html 3  
1 orassoc_accp3-060208ex.xml 3 3778
2 99.1 - EXPLANATION OF RESPONSES o4190810.txt EX-99 1765
  Complete submission text file 0000899140-08-001308.txt   7700
Mailing Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207
Business Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207 2149055100
ACCESS PHARMACEUTICALS INC (Issuer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 200 GREENWICH AVENUE, 3RD FLOOR GREENWICH CT 06830
Business Address 200 GREENWICH AVENUE, 3RD FLOOR GREENWICH CT 06830 203-862-1660
Oracle Associates LLC (Reporting) CIK: 0001317217 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-15771 | Film No.: 08891178